Coya Therapeutics, Inc. Common Stock (COYA) is a biotechnology company listed on NASDAQ.
Latest reported COYA revenue for 2025-12-31 was $7.9M. Net income was -$21.2M. Revenue was up 123.6% from 2024-12-31 to 2025-12-31. COYA currently screens at market cap $118.0M.
Use this COYA page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the COYA quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the COYA SEC filings page. Lician reads the product cache first so this HTML stays unique to Coya Therapeutics, Inc. Common Stock even when a live quote feed is slow.
Latest cached year on this hub. Full COYA income, balance, and cash tables.